Iliadis G, Zundel G, Brzezinski B
Institute of Physical Chemistry, University of Munich, Germany.
FEBS Lett. 1994 Oct 3;352(3):315-7. doi: 10.1016/0014-5793(94)00979-1.
Fourier transform (FTIR) difference spectra of pepsin minus diazoacetylnorleucine methyl ester (DAN) or minus diazoacetyl-L-phenylalanine methyl ester (DAP) modified pepsin, respectively, demonstrated that Asp-215 is not deprotonated in pepsin. The FTIR difference spectrum of pepsin minus 1,2-epoxyparanitrophenoxypropane (EPNP) modified pepsin demonstrates that Asp-32 is present in pepsin as CO2- anion. The position of the v(C = O) vibration demonstrates that no (O...H...O)- hydrogen bond between Asp-215 and Asp-32 is formed. Furthermore, no H3O+ is present in the active center. Studies of the complex of pepsin with the inhibitor pepstatin prove that the inhibitor removes the water from the active site and Asp-32 becomes protonated.
胃蛋白酶分别减去重氮乙酰正亮氨酸甲酯(DAN)或重氮乙酰-L-苯丙氨酸甲酯(DAP)修饰的胃蛋白酶后的傅里叶变换红外光谱(FTIR)差谱表明,在胃蛋白酶中Asp-215未去质子化。胃蛋白酶减去1,2-环氧对硝基苯氧基丙烷(EPNP)修饰的胃蛋白酶后的FTIR差谱表明,在胃蛋白酶中Asp-32以CO2-阴离子形式存在。v(C = O)振动的位置表明,Asp-215和Asp-32之间未形成(O...H...O)-氢键。此外,活性中心不存在H3O+。胃蛋白酶与抑制剂胃蛋白酶抑素复合物的研究证明,该抑制剂从活性位点去除了水,并且Asp-32被质子化。